Skip to main content

Table 5 Utility values, quality-adjusted life years (QALYs), and cost per patient along the five-year study period

From: Long-term cost-utility analysis of remote monitoring of older patients with pacemakers: the PONIENTE study

Variables All Conventional Monitoring group Remote Monitoring group Difference per patient
n Mean SD n Mean SD n Mean SD Mean dif. p-value
EQ5 DM00 55 0.71 0.36 34 0.72 0.36 21 0.70 0.38 0.02 0.795
EQ5 DM12 55 0.85 0.32 34 0.82 0.37 21 0.90 0.19 −0.08 0.301
EQ5 DM60 55 0.73 0.37 34 0.77 0.36 21 0.68 0.39 0.09 0.363
QALYM60 55 3.48 1.47 34 3.58 1.45 21 3.31 1.52 0.27 0.515
Cost/QALYM60 (€) 55 195.64 515.73 34 177.08 357.90 21 225.69 710.80 −48.61 0.773
Cost/patient (€) 55 325.28 142.91 34 356.62 144.12 21 274.53 128.45 82.10 0.033
ICER 301.16
  1. EQ–5D M12 EuroQoL five-dimensional questionnaire after 12 months; EQ–5D M60 EuroQoL five-dimensional questionnaire after 5 years; QALYM60 quality adjusted life years after 5 years; ICER incremental cost-effectiveness ratio (ICER), calculated as the difference in the expected cost per patient (€) divided by the difference in the QALY produced by the two interventions (CM and RM)
  2. 3% discount rate applied to annual costs and QALYs